STOJANOVIĆ, M.; BURSAĆ, D. Immunotoxicity of Pembrolizumab in patients with metastatic non-small cell lung cancer: A single-centre study. Archive of Oncology, v. 30, n. 1, p. 14–18, 13 Aug.2024.